Medincell (CHIX:MEDCLP) Total Tax Payable: €0.18 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:MEDCLP Medincell SA CHIX:MEDCLP
71 GF Score
Price €28.80
GF Value €27.22
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Medincell Total Tax Payable?

Medincell CHIX:MEDCLP 71 Total Tax Payable is €0.18 Mil as of Mar. 2026. GuruFocus rates CHIX:MEDCLP with a GF Score™ of 71/100 and a GF Value™ of €27.22 (Fairly Valued). The stock has 1 warning sign investors should review.

Medincell's Total Tax Payable for the quarter that ended in Mar. 2026 was €0.18 Mil.

Medincell's quarterly Total Tax Payable increased from Mar. 2025 (€0.09 Mil) to Sep. 2025 (€0.16 Mil) and increased from Sep. 2025 (€0.16 Mil) to Mar. 2026 (€0.18 Mil).

Medincell's annual Total Tax Payable declined from Mar. 2024 (€0.23 Mil) to Mar. 2025 (€0.09 Mil) but then increased from Mar. 2025 (€0.09 Mil) to Mar. 2026 (€0.18 Mil).

Medincell Total Tax Payable Historical Data

* Premium members only.

The historical data trend for Medincell's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medincell Total Tax Payable Chart

Medincell Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.59 0.23 0.09 0.18

Medincell Semi-Annual Data
Mar16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.13 0.09 0.16 0.18
CHIX:MEDCLP
71GF Score
Medincell SA CHIX:MEDCLP
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medincell Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of €0.18 Mil mean?
Medincell (CHIX:MEDCLP) has a Total Tax Payable of €0.18 Mil as of Mar. 2026. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Medincell and its competitors.
Is Medincell's Total Tax Payable too high?
Medincell's current Total Tax Payable is €0.18 Mil. Overall, Medincell has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medincell's Total Tax Payable compare to VRTX and REGN?
Medincell's Total Tax Payable of €0.18 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on Medincell and its competitors. Medincell's current Total Tax Payable is €0.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medincell stock overvalued right now?
Based on GuruFocus' analysis, Medincell (CHIX:MEDCLP) is currently considered Fairly Valued. The stock's GF Value™ is €27.22, compared to a current price of €28.80 — trading 5.8% above its estimated fair value. The current Total Tax Payable is €0.18 Mil. Medincell's overall GF Score™ is 71/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For Medincell (CHIX:MEDCLP), the current Total Tax Payable is €0.18 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medincell (CHIX:MEDCLP) Overvalued in 2026?

Based on GuruFocus' analysis, Medincell stock appears to be overvalued. The current stock price of €28.80 is trading 5.8% above its estimated GF Value™ of €27.22. GuruFocus considers Medincell to be Fairly Valued.

Key valuation signals for CHIX:MEDCLP:

  • Total Tax Payable: €0.18 Mil
  • GF Value™: €27.22 vs. price of €28.80 (5.8% above fair value)
  • GF Score™: 71/100 with 1 warning sign

No single metric tells the full story. See the CHIX:MEDCLP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medincell Business Description

Address 3 rue des Freres Lumiere, Jacou, FRA, 34830
Medincell SA is a technology-based pharmaceutical firm, aims to optimise the efficiency of medical treatments and make them accessible geographically. The company's product portfolio uses BEPO-patented technology to develop controlled, long-acting injectable medical treatments for a number of therapeutic fields. The firm has a single operating segment: ongoing research and development on processes that use biodegradable polymers to enable the controlled and prolonged release of the active principles of drugs into the human body and animals by means of injection.
71GF Score

Get the complete analysis for CHIX:MEDCLP

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.80
Price
€27.22
GF Value